Description

1-(Cyanomethyl)-n-(2,4-Dichlorophenyl)-3,4-Dihydro-2(1H)-Isoquinolinecarboxamide is a specialized heterocyclic organic compound featuring a unique isoquinoline carboxamide core. This molecule is of significant commercial interest as a high-value pharmaceutical intermediate and a key building block in advanced organic synthesis. It is primarily sought by R&D and production teams in the pharmaceutical and agrochemical industries for the development of novel active ingredients.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of potential drug candidates, particularly those targeting central nervous system (CNS) disorders or possessing antimicrobial properties.
• Agrochemical Research: Serves as a key scaffold for developing new-generation herbicides, fungicides, or insecticides, leveraging its dichlorophenyl and cyano functional groups.
• Chemical Synthesis Building Block: Used in academic and industrial research laboratories for constructing complex nitrogen-containing heterocycles for material science or catalysis.
• Protease Inhibitor Development: The carboxamide moiety makes it a candidate structure for designing enzyme inhibitors in biochemical research.
• Ligand Synthesis for Metal Complexes: Potential use in creating specialized ligands for catalytic or diagnostic applications.

Basic Information

Product Name	1-(Cyanomethyl)-n-(2,4-Dichlorophenyl)-3,4-Dihydro-2(1H)-Isoquinolinecarboxamide
CAS No.	339011-96-0
Molecular Formula	C18H15Cl2N3O
Molecular Weight	360.24 g/mol
Synonyms	1-(Cyanomethyl)-N-(2,4-dichlorophenyl)-3,4-dihydro-2(1H)-isoquinolinecarboxamide; 2(1H)-Isoquinolinecarboxamide, 1-(cyanomethyl)-N-(2,4-dichlorophenyl)-3,4-dihydro-; 1-(Cyanomethyl)-N-(2,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxamide; 339011-96-0; UNII-8G3G6T71L2; 8G3G6T71L2; CHEMBL3186035; DTXSID60635669
EINECS	Contact for details

Quality Control

Our production of 1-(Cyanomethyl)-n-(2,4-Dichlorophenyl)-3,4-Dihydro-2(1H)-Isoquinolinecarboxamide adheres to stringent internal quality protocols to ensure batch-to-batch consistency and high purity. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We commit to cGMP principles where applicable, and our quality systems are designed to meet the rigorous standards required for pharmaceutical intermediate supply.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be moisture-sensitive; keep the container tightly sealed in a dry environment. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.